Ultragenyx Pharmaceutical RARE
Last Price
52 Week Range
$18.41 - $46.50
Next Earnings Date
Feb 12 2026 (Estimate)
Next Earnings Date
Feb 12 2026 (Est.)
Last Price
RARE Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Ultragenyx Pharmaceutical Inc. | 8-K | December 30, 2025 | |
Ultragenyx Pharmaceutical Inc. | 8-K | December 29, 2025 | |
Ultragenyx Pharmaceutical Inc. | 10-Q | November 5, 2025 | |
Ultragenyx Pharmaceutical Inc. | 8-K | November 4, 2025 | |
Ultragenyx Pharmaceutical Inc. | 8-K | October 30, 2025 | |
Ultragenyx Pharmaceutical Inc. | 8-K | September 8, 2025 | |
Ultragenyx Pharmaceutical Inc. | 8-K | August 18, 2025 | |
Ultragenyx Pharmaceutical Inc. | 10-Q | August 6, 2025 | |
Ultragenyx Pharmaceutical Inc. | 8-K | August 5, 2025 | |
Ultragenyx Pharmaceutical Inc. | 8-K | July 31, 2025 | |
Ultragenyx Pharmaceutical Inc. | 8-K | July 11, 2025 | |
Ultragenyx Pharmaceutical Inc. | 8-K | July 9, 2025 | |
Ultragenyx Pharmaceutical Inc. | 8-K | June 27, 2025 | |
Ultragenyx Pharmaceutical Inc. | 8-K | May 19, 2025 | |
Ultragenyx Pharmaceutical Inc. | 10-Q | May 7, 2025 | |
Ultragenyx Pharmaceutical Inc. | 8-K | May 6, 2025 | |
Ultragenyx Pharmaceutical Inc. | DEF 14A | March 28, 2025 | |
Ultragenyx Pharmaceutical Inc. | DEFA14A | March 28, 2025 | |
Ultragenyx Pharmaceutical Inc. | ARS | March 28, 2025 | |
Ultragenyx Pharmaceutical Inc. | 10-K | February 19, 2025 | |
Ultragenyx Pharmaceutical Inc. | 8-K | February 13, 2025 | |
Ultragenyx Pharmaceutical Inc. | 8-K | January 13, 2025 | |
Ultragenyx Pharmaceutical Inc. | 8-K | December 19, 2024 | |
Ultragenyx Pharmaceutical Inc. | 8-K | December 19, 2024 | |
Ultragenyx Pharmaceutical Inc. | 8-K | November 12, 2024 | |
Ultragenyx Pharmaceutical Inc. | 10-Q | November 6, 2024 | |
Ultragenyx Pharmaceutical Inc. | 8-K | November 5, 2024 | |
Ultragenyx Pharmaceutical Inc. | 8-K | October 7, 2024 | |
Ultragenyx Pharmaceutical Inc. | 8-K | October 3, 2024 | |
Ultragenyx Pharmaceutical Inc. | 10-Q | August 2, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.